People · Operator
Named in public records as an officer, director or promoter · active 2010–2021 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Marius Pharmaceuticals, LLC | — | Pharmaceuticals | Series B | $11.6M | $129.3M | 2019 |
| Black Swan Pharmaceuticals, Inc. | — | Pharmaceuticals | Seed | $2.0M | $38.9M | 2020 |
| SOV Therapeutics, Inc. | — | Pharmaceuticals | Pre-Seed | $425K | $10.6M | 2010 |
Om Dhingra at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Om Dhingra on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Himanshu Shah | 2 | 2 |
| Amit Shah | 1 | 10 |
| Shalin Shah | 1 | 2 |
| Steve Arnott | 1 | 1 |
| Julian Arbuckle | 1 | 1 |
| Craig Metz | 1 | 1 |
| Arun Shukla | 1 | 1 |
| Satinder Sethi | 1 | 1 |
| Himanshu H. Shah | 1 | 1 |
| Anthony Akkari | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.